182 related articles for article (PubMed ID: 12798881)
41. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
[TBL] [Abstract][Full Text] [Related]
42. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
Kingsberg S
J Sex Med; 2007 Mar; 4 Suppl 3():227-34. PubMed ID: 17394595
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial.
Vale FBC; Zanolla Dias de Souza K; Rezende CR; Geber S
Gynecol Endocrinol; 2018 May; 34(5):442-445. PubMed ID: 29172782
[TBL] [Abstract][Full Text] [Related]
44. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
El-Hage G; Eden JA; Manga RZ
Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
[TBL] [Abstract][Full Text] [Related]
45. Safety of estrogen/androgen regimens.
Simon JA
J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
[TBL] [Abstract][Full Text] [Related]
46. Determining the effects of androgen therapy on sexual well-being: a complex challenge.
Davis SR
Menopause; 2005; 12(4):359-60. PubMed ID: 16037748
[No Abstract] [Full Text] [Related]
47. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
48. Men's sexual response to female partner's intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study.
Muin DA; Sheikh Rezaei S; Tremmel-Scheinost M; Salama M; Luger A; Wolzt M; Husslein PW; Bayerle-Eder M
Fertil Steril; 2017 Mar; 107(3):781-787.e3. PubMed ID: 28189292
[TBL] [Abstract][Full Text] [Related]
49. Testosterone therapy for sexual dysfunction in postmenopausal women.
Hubayter Z; Simon JA
Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
[TBL] [Abstract][Full Text] [Related]
50. Female hypoactive sexual disorder: case studies of physiologic androgen replacement.
Warnock JK; Bundren JC; Morris DW
J Sex Marital Ther; 1999; 25(3):175-82. PubMed ID: 10407790
[TBL] [Abstract][Full Text] [Related]
51. Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.
Kalantaridou SN; Vanderhoof VH; Calis KA; Corrigan EC; Troendle JF; Nelson LM
Fertil Steril; 2008 Nov; 90(5):1805-11. PubMed ID: 17961560
[TBL] [Abstract][Full Text] [Related]
52. Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels.
Elaut E; De Cuypere G; De Sutter P; Gijs L; Van Trotsenburg M; Heylens G; Kaufman JM; Rubens R; T'Sjoen G
Eur J Endocrinol; 2008 Mar; 158(3):393-9. PubMed ID: 18299474
[TBL] [Abstract][Full Text] [Related]
53. The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy.
Davis SR; Hirschberg AL; Wagner LK; Lodhi I; von Schoultz B
J Clin Endocrinol Metab; 2009 Dec; 94(12):4907-13. PubMed ID: 19850682
[TBL] [Abstract][Full Text] [Related]
54. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues.
Warnock JK; Bundren JC; Morris DW
Psychopharmacol Bull; 1997; 33(4):761-6. PubMed ID: 9493489
[TBL] [Abstract][Full Text] [Related]
55. Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women.
Scott G; Yiu SC; Wasilewski D; Song J; Smith RE
Am J Ophthalmol; 2005 Jun; 139(6):1109-10. PubMed ID: 15953447
[TBL] [Abstract][Full Text] [Related]
56. Patient scenario: a 53-year-old woman with hypoactive sexual desire disorder.
Palacios S; Graziottin A
Maturitas; 2009 Jun; 63(2):164-8. PubMed ID: 19487091
[TBL] [Abstract][Full Text] [Related]
57. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
58. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
Bloch M; Meiboom H; Zaig I; Schreiber S; Abramov L
Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
Cayan F; Dilek U; Pata O; Dilek S
J Sex Med; 2008 Jan; 5(1):132-8. PubMed ID: 17961145
[TBL] [Abstract][Full Text] [Related]
60. Potential role of androgens in the treatment of hypoactive sexual desire in women.
Clayton AH
Womens Health (Lond); 2005 Sep; 1(2):191-3. PubMed ID: 19803836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
